Drug Approval | April 10, 2024
NATCO Pharma receives warning letter from USFDA for facility in Kothur, Telangana
The company will respond to the Warning Letter within the stipulated timelines
The company will respond to the Warning Letter within the stipulated timelines
These observations are procedural in nature and will be responded within the stipulated time
A game changing solution for the pharmaceutical industry
The observations are procedural in nature and will be responded to within the stipulated time
The Product is expected to be the first generic approval on the market
Highly effective preservation solutions ensuring the safety and protection of personal care products
_256_384.jpg)
The regulator carried out a routine current Good Manufacturing Practices (cGMP) inspection from March 28 to April 4.
Abecma tripled progression-free survival compared to standard regimens in the Phase 3 KarMMa-3 trial
Enhertu now has five approved indications with the latest in HER2-expressing (IHC 3+) metastatic cancers
The company plans to add 1700 beds by FY27 through the organic route
Subscribe To Our Newsletter & Stay Updated
